WebDec 5, 2024 · BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced positive Phase 1b clinical data for BGE-105, a highly selective, potent, orally available small-molecule agonist of the apelin receptor APJ. WebApr 10, 2024 · Some 400 biopharmaceutical company executives have signed the letter, including incoming BIO president Dr. Ted Love, who also is the president and CEO of Global Blood Therapeutics of South San ...
Did you know?
WebAug 19, 2024 · BioAge Labs, Inc., a clinical-stage biotechnology company, appoints Rekha Hemrajani and Jason Coloma to its Board of Directors ... Jason Coloma, MBA, Ph.D., is CEO of Maze Therapeutics, Inc. a ... WebNov 18, 2024 · Paul leads the clinical development of BIOAGE's pipeline of therapies that target aging. Paul is an experienced pharma and biotech executive with extensive experience in small molecules, biologics and oligonucleotide therapeutics and has advanced dozens of compounds from discovery through approval.
WebDec 5, 2024 · BioAge Labs has concluded a Phase 1b study in which human volunteers undergoing 10 days of bed rest were shown to have their related muscle atrophy significantly attenuated by BGE-105. … WebHe currently serves as the Chief Financial Officer at BioAge.Previously, he was the Chief Financial Officer and Chief Business Officer of Indapta Therapeutics, a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRy-deficient natural killer (G-NK) cell therapy to treat multiple types of ...
WebMay 31, 2024 · RICHMOND, Calif.--(BUSINESS WIRE)-- BioAge Labs, Inc. (“BioAge”, “the Company”), a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that Kristen Fortney, PhD, CEO and Co-Founder of BioAge, will lead a panel discussion at the BIO … WebBioAge Labs 7,131 followers on LinkedIn. We are mapping human aging to develop a pipeline of therapies to treat disease and extend healthy lifespan. BioAge is a platform-driven, clinical-stage ...
WebNov 7, 2024 · BioAge Labs, PTC Therapeutics, Biogen and others highlighted these approaches at the Cambridge Innovation Institute's recent Discovery on Target meeting. …
WebApr 19, 2024 · RICHMOND, Calif., April 19, 2024--BioAge Labs, Inc., a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced ... flight virgin atlanticWebAug 24, 2024 · RICHMOND, Calif., August 24, 2024--BioAge Labs, Inc. ("BioAge", "the Company"), a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human ... greater anglia live train timesWebWe work in the fields of drug discovery, analytical chemistry and environmental and water analysis. Our customers are pharmaceutical companies, analytical testing groups and … greater anglia lost smart cardWebJan 26, 2024 · BioAge plans to initiate a Phase 2 trial for treatment of COVID-19 in the first half of 2024. ... We are not limiting ourselves to the research and development of therapeutics, but are also pursuing total care for infectious diseases, through awareness building, prevention, diagnosis, and addressing exacerbations, as well as the treating the ... greater anglia managing directorWebOct 13, 2024 · RICHMOND, Calif., October 13, 2024--BioAge Labs, Inc. ("BioAge"), a privately held clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend ... flight vijayawada to delhiWebOct 13, 2024 · RICHMOND, Calif.--(BUSINESS WIRE)-- BioAge Labs, Inc. (“BioAge”), a privately held clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that it will present updates on its NLRP3 inhibitor program at two upcoming conferences in the … greater anglia live timetableWebApr 19, 2024 · RICHMOND, Calif.--(BUSINESS WIRE)--BioAge Labs, Inc., a biotechnology company developing therapeutics that target the molecular causes of aging to extend … greater anglia md